• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 17th April 2018

New Methods for Analysing the Distribution of EQ-5D Observations

Our latest OHE Research Paper presents new methods for summarising EQ-5D data from patients. Our latest OHE Research Paper has been published, presenting new methods for analysing the distribution of EQ-5D observations, led by Bernarda Zamora.   EQ-5D profile data…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
CambdridgeHSDC_forBlog

Our latest OHE Research Paper presents new methods for summarising EQ-5D data from patients.

Our latest OHE Research Paper has been published, presenting new methods for analysing the distribution of EQ-5D observations, led by Bernarda Zamora.
 
EQ-5D profile data – that is, the levels of problems reported on each of the five dimensions of health – are often under-analysed. Where the data are used to estimate QALYs, the profile data are summarised using value sets, and the profile data provided by patients is not itself the focus of analysis. Yet the profile data can yield important insights into the specific aspects of health problems that patients are experiencing, and how these change, for example, as a result of treatment. 
 
One thing to look out for in self-reported health on the EQ-5D (and other ‘generic’ outcome measures) is the extent to which the health states reported by patients cluster together in a small number of profiles or are dispersed evenly over many profiles. This can have implications for interpreting statistical analysis of the corresponding EQ values (Index) data, and for clinical management of patients.
 
Our latest OHE Research Paper presents new methods that we have developed to summarise the distribution of health states in patient reported outcome (PRO) data, with application to EQ-5D profile data in the UK. They are the Health State Density Index (HSDI), Health State Density Curve (HSDC), and estimated Power Law functions (PLFs). The properties of these are examined and compared with existing methods from information theory (e.g. Shannon’s Index).
 
These methods can be used to generate evidence on the relative performance of different instruments. For example, the HSDCs and HSDIs can be used to examine the differences between the three- and five-level versions of the EQ-5D with respect to how much clustering there is in the profile data. Because of the more granular descriptions of health provided by the additional levels of the 5L, the profile data from the 5L are less clustered than that from the 3L. The methods we present in this paper provide a simple way of summarising this graphically (HSDC) and via a single number (HSDI). 
 
 
 
These methods can also be used by clinicians to help with treatment planning. For example, if patients’ pre-treatment EQ-5D data show that most patients’ health problems are captured by a small number of profiles, this might suggest their health needs are homogeneous and can be managed with standardised treatment protocols. However, if a wide range of EQ-5D profiles is reported by patients, this may suggest a greater need for individualised patient management. 
 
The study was undertaken by Bernarda Zamora, David Parkin, Yan Feng, Mike Herdman, and Nancy Devlin (PI), in collaboration with Andrew Bateman of Cambridgeshire Community Services NHS Trust and University of Cambridge. Preliminary findings were presented at the HESG Winter 2017, PROMs conference 2017, and the 2017 EuroQol Plenary Meeting. The study was funded by the EuroQol Research Foundation.
 
Click here to download the full report.
 
For more information about OHE’s research on this topic, contact Bernarda Zamora.
 
Related research:
Feng, Y., Devlin, N., Bateman, A., Zamora, B. and Parkin, D., 2016. The Distribution of the EQ-5D-5L Index in Patient Populations. OHE Research Paper. [RePEc]
 
Parkin, D., Devlin, N. and Feng, Y., 2016. What Determines the Shape of an EQ-5D Index Distribution? Medical Decision Making, 36(8), 941-951. [DOI] [RePEc]
 
Parkin, D., Rice, N. and Devlin, N., 2010. Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? Medical Decision Making, 30(5), 556-565. [DOI]
 
  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Research Papers

Related News

  • News
  • December 2020

Should We ‘Drop Dead’ from Health State Valuation?

Read more
  • News
  • September 2020

Cornerstones of ‘Fair’ Drug Coverage

Read more
  • News
  • January 2020

Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead

Read more
  • News
  • September 2019

HTA and Payment Mechanisms for New Drugs to Tackle AMR

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!